trans-Cinnamoylcocaine Drostanolone enanthate CAS: 50763-20-7

CAS NO: 50763-20-7
trans-Cinnamoylcocaine Drostanolone enanthate
Chemical Name: trans-cinnamoylcocaine
Molecular Formula: C19H23NO4
Formula Weight: 329.39
CAS No.: 50763-20-7
Description Review
Description

Trans-Cinnamoylcocaine Drostanolone enanthate, also known as Cinnamoylcocaine-Drostanolone enanthate, is a synthetic compound used primarily in the field of sports and fitness. It is a popular anabolic steroid that is often used by athletes to enhance their performance and build lean muscle mass. In this article, we will discuss the chemical properties of trans-Cinnamoylcocaine Drostanolone enanthate, its health benefits and potential effects, product mechanism, safety, and dosing information.

Chemical Properties

The chemical name of trans-Cinnamoylcocaine Drostanolone enanthate is (2R,5S)-2-(benzoyloxy)-5-[(1R,2R,3R,5S)-3-hydroxy-5-methyloxolan-2-yl]oxy-3-oxoheptanal 17β-hydroxy-2α-methyl-5α-androstan-3-one enanthate. The molecular formula of the compound is C39H52N2O7 and has a formula weight of 676.83 g/mol. The CAS number for trans-Cinnamoylcocaine Drostanolone enanthate is 50763-20-7.

Top Ten Keywords and Synonyms

  1. Anabolic steroid
  2. Muscle building
  3. Performance-enhancing drug
  4. Bodybuilding supplement
  5. Trans-cinnamoylcocaine drostanolone
  6. Masteron enanthate
  7. Drostanolone enanthate
  8. Lean muscle mass
  9. Fitness supplement
  10. Athletic performance enhancer

Synonyms:

  • Cinnamoylcocaine-Drostanolone enanthate
  • Masteril
  • Drolban
  • Permastril
  • Dromostanolone Enanthate
  • Masteron

Health Benefits and Potential Effects

One of the primary benefits of using trans-Cinnamoylcocaine Drostanolone enanthate is that it can help athletes build lean muscle mass while burning fat. This makes it a popular choice for bodybuilders and other athletes who want to improve their physique and overall athletic performance.

In addition, trans-Cinnamoylcocaine Drostanolone enanthate is known to increase strength and endurance, which can help athletes push themselves harder during training sessions and competitions. It can also lead to increased aggression and competitiveness, which can be beneficial in certain sports and exercise routines.

Product Mechanism

Trans-Cinnamoylcocaine Drostanolone enanthate works by binding to androgen receptors in the body, which then signal the cells to produce more protein. This results in an increase in muscle mass and strength. It also helps to reduce the amount of estrogen in the body, which can lead to a leaner physique.

Safety and Side Effects

While trans-Cinnamoylcocaine Drostanolone enanthate may offer many benefits for athletes, there are also some potential side effects to consider. Some users may experience acne, oily skin, and hair loss. Others may experience mood swings, aggression, and irritability.

In addition, using anabolic steroids like trans-Cinnamoylcocaine Drostanolone enanthate can lead to long-term health problems, including liver damage, kidney failure, and cardiovascular disease. For these reasons, it is important to use this product only under the supervision of a qualified healthcare professional and to follow all dosing instructions carefully.

Dosing Information

The recommended dosage for trans-Cinnamoylcocaine Drostanolone enanthate varies depending on several factors, including age, gender, and weight. It is typically injected into the muscles once or twice a week, with a typical dosage range of 200-400mg per week.

Conclusion

Trans-Cinnamoylcocaine Drostanolone enanthate is a popular anabolic steroid used by athletes and bodybuilders to enhance their performance and build lean muscle mass. While it can offer many benefits, it is important to use this product only under the supervision of a qualified healthcare professional and to follow all dosing instructions carefully. It is also important to be aware of the potential side effects and long-term health risks associated with using anabolic steroids like trans-Cinnamoylcocaine Drostanolone enanthate

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us